Qing Zhu

Also affiliated with Key Laboratory of Guangdong Province, Guangdong Provincial Hospital of Traditional Chinese Medicine, Yunnan Machinery Research and Design Institute, Southwest Jiaotong University

EngineeringMedicineEnvironmental ScienceEarth and Planetary Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial”.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00751-9

N/A

6.2DataRank · unranked

194 citations

Uriel Sandkovsky, Cavan S. Reilly, David M. Vock, Robert L. Gottlieb, Michael Mack +95 more

Large intestine–targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection

UNC Libraries(2020)10.17615/9bzz-zk72

N/A

0.241DataRank · unranked

4 citations

James Kirk, Guofeng Zhang, Dennis M. Klinman, Tshaka Cunningham, Jay A. Berzofsky +9 more